Abstract: The present invention provides antiviral proteins (collectively referred to as cyanovirins), conjugates thereof, DNA sequences encoding such agents, host cells containing such DNA sequences, antibodies directed to such agents, compositions comprising such agents, and methods of obtaining and using such agents.
Type:
Grant
Filed:
April 26, 1996
Date of Patent:
October 13, 1998
Assignee:
The United States of Americaa as represented by the Secretary of the Department of Health and Human Services
Inventors:
Michael R. Boyd, Kirk R. Gustafson, Robert H. Shoemaker, James B. McMahon